Dr. Ayman Daoud, MD

NPI: 1073640355
Total Payments
$2,987
2024 Payments
$494.56
Companies
30
Transactions
155
Medicare Patients
2,410
Medicare Billing
$370,374

Payment Breakdown by Category

Food & Beverage$2,987 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,987 155 100.0%

Top Paying Companies

Company Total Records Latest Year
ACADIA Pharmaceuticals Inc $445.19 23 $0 (2024)
Lilly USA, LLC $284.81 17 $0 (2024)
ABBVIE INC. $241.81 12 $0 (2024)
Daiichi Sankyo Inc. $230.00 2 $0 (2019)
Sunovion Pharmaceuticals Inc. $202.87 10 $0 (2022)
GlaxoSmithKline, LLC. $193.61 13 $0 (2024)
AstraZeneca Pharmaceuticals LP $146.08 9 $0 (2024)
Regeneron Healthcare Solutions, Inc. $130.00 1 $0 (2023)
Teva Pharmaceuticals USA, Inc. $127.45 11 $0 (2018)
Novartis Pharmaceuticals Corporation $123.12 7 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $494.56 24 Mylan Specialty L.P. ($105.73)
2023 $483.89 26 ACADIA Pharmaceuticals Inc ($138.97)
2022 $445.39 26 Lilly USA, LLC ($83.32)
2021 $362.98 22 Lilly USA, LLC ($89.30)
2020 $275.30 16 Sunovion Pharmaceuticals Inc. ($40.16)
2019 $601.68 26 Daiichi Sankyo Inc. ($230.00)
2018 $192.13 13 Teva Pharmaceuticals USA, Inc. ($127.45)
2017 $130.69 2 ACADIA Pharmaceuticals Inc ($118.84)

All Payment Transactions

155 individual payment records from CMS Open Payments — Page 1 of 7

Date Company Product Nature Form Amount Type
12/02/2024 Mylan Specialty L.P. YUPELRI (Drug) Food and Beverage In-kind items and services $25.08 General
Category: Anticholinergics, Inhaled
11/06/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $21.13 General
Category: Cardiology/Vascular Diseases
10/15/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $22.88 General
Category: RESPIRATORY
09/19/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $17.16 General
Category: Cardiology/Vascular Diseases
09/17/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $13.84 General
Category: Diabetes
09/10/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $25.12 General
Category: PAIN
08/14/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $19.45 General
Category: PARKINSONS DISEASE PSYCHOSIS
08/07/2024 Mylan Specialty L.P. YUPELRI (Drug) Food and Beverage In-kind items and services $27.01 General
Category: Anticholinergics, Inhaled
07/29/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $19.64 General
Category: PARKINSONS DISEASE PSYCHOSIS
07/17/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $13.17 General
Category: RESPIRATORY
07/03/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $19.05 General
Category: PARKINSONS DISEASE PSYCHOSIS
07/02/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $15.18 General
Category: PAIN
06/07/2024 Mylan Specialty L.P. YUPELRI (Drug) Food and Beverage In-kind items and services $26.68 General
Category: Anticholinergics, Inhaled
06/05/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $19.95 General
Category: Respiratory
05/21/2024 PFIZER INC. NURTEC ODT (Drug) Food and Beverage In-kind items and services $22.67 General
Category: PAIN
05/08/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $17.89 General
Category: Diabetes
04/25/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $31.95 General
Category: NEUROSCIENCE
04/24/2024 Mylan Specialty L.P. YUPELRI (Drug) Food and Beverage In-kind items and services $26.96 General
Category: Anticholinergics, Inhaled
04/16/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $13.74 General
Category: RESPIRATORY
03/08/2024 GlaxoSmithKline, LLC. SHINGRIX (Biological) Food and Beverage In-kind items and services $16.23 General
Category: VACCINES
03/05/2024 Indivior Inc. SUBLOCADE (Drug) Food and Beverage In-kind items and services $17.23 General
Category: OUD
02/14/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $18.29 General
Category: Oncology
02/04/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $18.42 General
Category: PARKINSONS DISEASE PSYCHOSIS
01/24/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $25.84 General
Category: PAIN
12/11/2023 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $24.81 General
Category: PARKINSONS DISEASE PSYCHOSIS

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 15 447 1,041 $112,060 $59,080
2022 16 566 1,468 $153,365 $79,238
2021 18 586 1,659 $165,615 $102,685
2020 21 811 1,994 $220,055 $129,370
Total Patients
2,410
Total Services
6,162
Medicare Billing
$370,374
Procedure Codes
70

All Medicare Procedures & Services

70 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 56 186 $34,460 $16,662 48.4%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 32 104 $14,040 $10,038 71.5%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 38 141 $13,395 $9,048 67.5%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 48 58 $15,370 $8,055 52.4%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 39 44 $8,580 $4,028 46.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 29 69 $8,970 $4,002 44.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 12 19 $4,750 $2,739 57.7%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 12 12 $2,655 $1,557 58.6%
96372 Injection of drug or substance under skin or into muscle Office 2023 26 89 $2,670 $913.68 34.2%
80061 Blood test, lipids (cholesterol and triglycerides) Office 2023 39 52 $1,300 $656.00 50.5%
83036 Hemoglobin a1c level Office 2023 38 54 $1,080 $495.04 45.8%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 33 41 $1,230 $445.52 36.2%
94010 Test to measure expiratory airflow and volume Office 2023 15 16 $1,040 $343.68 33.0%
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg Office 2023 18 60 $600.00 $65.05 10.8%
J1885 Injection, ketorolac tromethamine, per 15 mg Office 2023 12 96 $1,920 $32.44 1.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 66 305 $56,425 $27,670 49.0%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 53 163 $22,005 $13,589 61.8%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 60 66 $17,490 $10,646 60.9%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 36 146 $13,870 $8,476 61.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 46 108 $14,040 $6,929 49.4%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 44 47 $9,165 $3,994 43.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 17 22 $5,500 $2,829 51.4%
96372 Injection of drug or substance under skin or into muscle Office 2022 37 129 $3,870 $1,435 37.1%
80061 Blood test, lipids (cholesterol and triglycerides) Office 2022 52 67 $1,675 $874.75 52.2%
20610 Aspiration and/or injection of fluid from large joint Office 2022 11 17 $1,620 $820.81 50.7%

About Dr. Ayman Daoud, MD

Dr. Ayman Daoud, MD is a Internal Medicine healthcare provider based in Canton, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1073640355.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ayman Daoud, MD has received a total of $2,987 in payments from pharmaceutical and medical device companies, with $494.56 received in 2024. These payments were reported across 155 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($2,987).

As a Medicare-enrolled provider, Daoud has provided services to 2,410 Medicare beneficiaries, totaling 6,162 services with total Medicare billing of $370,374. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Canton, MI
  • Active Since 02/27/2007
  • Last Updated 02/25/2015
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1073640355

Products in Payments

  • NUPLAZID (Drug) $445.19
  • INJECTAFER (Drug) $230.00
  • UBRELVY (Drug) $143.61
  • NURTEC ODT (Drug) $137.34
  • TRULICITY (Drug) $130.52
  • LIBTAYO (Biological) $130.00
  • TRELEGY ELLIPTA (Drug) $120.02
  • YUPELRI (Drug) $105.73
  • QULIPTA (Drug) $89.16
  • AJOVY (Drug) $80.38
  • ENTRESTO (Drug) $79.10
  • Mavenclad (Biological) $73.19
  • EMGALITY (Drug) $73.18
  • ELIQUIS (Drug) $66.78
  • TROKENDI XR (Drug) $64.08
  • FARXIGA (Drug) $63.54
  • MOUNJARO (Drug) $63.05
  • XARELTO (Drug) $58.81
  • LONHALA MAGNAIR (Drug) $56.64
  • GEMTESA (Drug) $56.20

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Canton